| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | Director | Common Stock | 1,261,779 | $3,457,274 | $2.74 | 23 May 2023 | Direct |
| Sysorex, Inc. | Director | Common Stock | 75,000 | 03 Sep 2021 | Direct | ||
| ADIAL PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 50,000 | 23 May 2023 | Direct | ||
| Avalon GloboCare Corp. | Director | Stock Option (right to buy) | 8,000 | 01 Jan 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADIL | ADIAL PHARMACEUTICALS, INC. | 23 May 2023 | 2 | $0 | 4 | Director | 25 May 2023, 16:47 |
| ADIL | ADIAL PHARMACEUTICALS, INC. | 30 Dec 2022 | 1 | $0 | 4 | Director | 03 Jan 2023, 05:02 |
| ADIL | ADIAL PHARMACEUTICALS, INC. | 22 Aug 2022 | 1 | $0 | 4 | Director | 23 Aug 2022, 19:14 |
| ADIL | ADIAL PHARMACEUTICALS, INC. | 23 Feb 2022 | 1 | $0 | 4 | Chief Executive Officer, Director | 25 Feb 2022, 14:00 |
| ADIL | ADIAL PHARMACEUTICALS, INC. | 29 Nov 2021 | 2 | $55,070 | 4 | Chief Executive Officer, Director, 10%+ Owner | 01 Dec 2021, 08:25 |
| SYSX | Sysorex, Inc. | 03 Sep 2021 | 1 | $0 | 4 | Director | 10 Sep 2021, 20:45 |
| SYSX | Sysorex, Inc. | 03 Sep 2021 | 0 | $0 | 3 | Director | 10 Sep 2021, 20:44 |
| ALBT | Avalon GloboCare Corp. | 01 Jan 2021 | 3 | $0 | 4 | Director | 08 Mar 2023, 15:45 |